Incidence of Diabetes and its Control Measures in AIDS PatientsHima Bindu A1* and Soumya D2
- *Corresponding Author:
- Hima Bindu A
P.G Department of Biotechnology
Andhra Vidyalaya P.G College
Affiliated to Osmania University
E-Mail: [email protected]
Received date November 10, 2011; Accepted date December 11, 2011; Published date December 16, 2011
Citation: Hima Bindu A, Soumya D (2011) Incidence of Diabetes and its Control Measures in AIDS Patients. J Diabetes Metab 2:169. doi:10.4172/2155-6156.1000169
Copyright: © 2011 Hima Bindu A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
HIV and diabetes are both chronic diseases that significantly affect the human lifestyle and their quality of living. When these two diseases coexist, their treatment would be overwhelming for patients. Highly active antiretroviral therapy (HAART) became the standard of care in HIV infection. As the treatment for HIV has been developed and the access to therapy has been improved, the incidence of HIV-associated diabetes began to grow. Diabetes can be an important consequence of HAART. This review describes various metabolic complications such as AIDS-related insulin resistance, Glucose Intolerance and Hyperglycemia after HAART and also gives a brief account on the control measures.